Cargando…

Immunotherapy of SARS based on combinations of neutralizing human monoclonal antibodies

Evaluation of: Coughlin MM, Babcook J, Prabhakar BS: Human monoclonal antibodies to SARS-coronavirus inhibit infection by different mechanisms. Virology 394(1), 39–46 (2009). This work discusses passive immunotherapy based on neutralizing human monoclonal antibodies (mAbs) with different mechanisms...

Descripción completa

Detalles Bibliográficos
Autores principales:	Du, Lanying, Jiang, Shibo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2010
Materias:	Priority Paper Evaluation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079818/ https://www.ncbi.nlm.nih.gov/pubmed/32201501 http://dx.doi.org/10.2217/fvl.09.78

Ejemplares similares

Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
por: Jiang, Shibo, et al.
Publicado: (2020)

Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2
por: Tai, Wanbo, et al.
Publicado: (2020)

Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses: (Trends in Immunology 41, 355–359; 2020)
por: Jiang, Shibo, et al.
Publicado: (2020)

Effects of a novel Nodal-targeting monoclonal antibody in melanoma
por: Strizzi, Luigi, et al.
Publicado: (2015)

Development of a safe and convenient neutralization assay for rapid screening of influenza HA-specific neutralizing monoclonal antibodies
por: Du, Lanying, et al.
Publicado: (2010)

How can we interpret SARS-CoV-2 antibody test results?
por: Føns, Sofie, et al.
Publicado: (2021)

Antibodies induced by receptor-binding domain in spike protein of SARS-CoV do not cross-neutralize the novel human coronavirus hCoV-EMC
por: Du, Lanying, et al.
Publicado: (2013)

Effect of Low-Pathogenic Human Coronavirus-Specific Antibodies on SARS-CoV-2
por: Jiang, Shibo, et al.
Publicado: (2020)

A monoclonal antibody against the Wnt signaling inhibitor dickkopf-1 inhibits osteosarcoma metastasis in a preclinical model
por: Goldstein, Seth D., et al.
Publicado: (2016)

Cross-neutralization of SARS coronavirus-specific antibodies against bat SARS-like coronaviruses
por: Zeng, Lei-Ping, et al.
Publicado: (2017)

Comparison of SARS-CoV-2 RT-PCR on a high-throughput molecular diagnostic platform and the cobas SARS-CoV-2 test for the diagnostic of COVID-19 on various clinical samples
por: Opota, Onya, et al.
Publicado: (2020)

An oligoclonal combination of human monoclonal antibodies able to neutralize tetanus toxin in vivo
por: Aliprandini, Eduardo, et al.
Publicado: (2019)

Neutralization of Zika virus by germline-like human monoclonal antibodies targeting cryptic epitopes on envelope domain III
por: Wu, Yanling, et al.
Publicado: (2017)

Enhanced immunotherapy by combining a vaccine with a novel murine GITR ligand fusion protein
por: Morillon, Y. Maurice, et al.
Publicado: (2017)

4401 Incidence, management, and outcomes of immune-related adverse events (irAEs): an analysis of a multidisciplinary toxicity team for cancer immunotherapy related irAEs
por: Balaji, Aanika, et al.
Publicado: (2020)

Neutralizing monoclonal antibodies against highly pathogenic coronaviruses
por: Xiang, Rong, et al.
Publicado: (2022)

Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections
por: Ying, Tianlei, et al.
Publicado: (2015)

Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2
por: Yu, Fei, et al.
Publicado: (2020)

Broad neutralization of SARS-related viruses by human monoclonal antibodies
por: Wec, Anna Z., et al.
Publicado: (2020)

Asymptomatic SARS-CoV-2 infection: is it all about being refractile to innate immune sensing of viral spare-parts?—Clues from exotic animal reservoirs
por: Shankar, Esaki M, et al.
Publicado: (2020)

Enhanced antitumor effects by combining an IL-12/anti-DNA fusion protein with avelumab, an anti-PD-L1 antibody
por: Fallon, Jonathan K., et al.
Publicado: (2017)

Immune Determinants of the Association between Tumor Mutational Burden and Immunotherapy Response across Cancer Types
por: Sinha, Neelam, et al.
Publicado: (2022)

4365 Family-Based Study of Sleep in Autism Spectrum Disorder without Intellectual Disability
por: Smidt, Stacey Elkhatib, et al.
Publicado: (2020)

4034 Can Connections IN Health become a research-based model to improve health outcomes through community health coalitions?
por: Darbishire, Lily, et al.
Publicado: (2020)

A predicted receptor-binding and critical neutralizing domain in S protein of the novel human coronavirus HCoV-EMC
por: Jiang, Shibo, et al.
Publicado: (2013)

Neutralizing antibodies and their cocktails against SARS-CoV-2 Omicron and other circulating variants
por: Yang, Yang, et al.
Publicado: (2022)

Enhanced killing of chordoma cells by antibody-dependent cell-mediated cytotoxicity employing the novel anti-PD-L1 antibody avelumab
por: Fujii, Rika, et al.
Publicado: (2016)

SARS-CoV-2 causes senescence in human cells and exacerbates the senescence-associated secretory phenotype through TLR-3
por: Tripathi, Utkarsh, et al.
Publicado: (2021)

Tumor antigen CA125 suppresses antibody-dependent cellular cytotoxicity (ADCC) via direct antibody binding and suppressed Fc-γ receptor engagement
por: Kline, James Bradford, et al.
Publicado: (2017)

SARS-CoV-2 spike protein: a key target for eliciting persistent neutralizing antibodies
por: Yang, Yang, et al.
Publicado: (2021)

Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses
por: Chen, Yanjia, et al.
Publicado: (2022)

Human neutralizing antibodies for SARS-CoV-2 prevention and immunotherapy
por: Zhou, Dongyan, et al.
Publicado: (2021)

Échelle de somatisation : faire la différence entre les symptômes du Covid-19 et la somatisation chez le jeune adulte et chez les sujets âgés
por: Kettani, Z.
Publicado: (2020)

4526 Coping with End of Life Care: Compassion Fatigue and Burnout Effects on Cortisol Patterns of Health Care Providers Caring for Children
por: Sanchez-Plazas, Liza Carolina, et al.
Publicado: (2020)

4299 The University of North Carolina CTSA Hub (NC TraCS) Service Evaluation: Using Customer Feedback to Improve Services
por: McKinley, Shayne Thomas, et al.
Publicado: (2020)

4051 Assessing outcomes of Miami CTSI’s Mentored Career Development KL2 Program: Using bibliometric and network visualization approaches to complement traditional outcome metrics
por: Das, Rosalina, et al.
Publicado: (2020)

4300 Evaluation and structure of the pilot funding program at the University of North Carolina CTSA Hub (NC TraCS)
por: Morozumi, Kalene, et al.
Publicado: (2020)

4113 Infusing a CTSA Program with Causal Pathway Thinking to Transform Evaluation from Operations to Impacts
por: Kost, Rhonda G, et al.
Publicado: (2020)

4142 Implementation of Consent-to-Contact (CTC) initiative at an Academic Medical center: Initial operationalization and lessons learned
por: Lee, Chin Chin, et al.
Publicado: (2020)

4014 Results of a Formative Evaluation of the Cardiopulmonary Vascular Biology (CPVB) Center of Biomedical Research Excellence (COBRE)
por: Kimberly, Judy, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j30tisvdb54oogglplqa2gk2ii